Mutations Causing Childhood Ataxia with Central Nervous System Hypomyelination Reduce Eukaryotic Initiation Factor 2B Complex Formation and Activity
Overview
Affiliations
Childhood ataxia with central nervous system hypomyelination (CACH), or vanishing white matter leukoencephalopathy (VWM), is a fatal brain disorder caused by mutations in eukaryotic initiation factor 2B (eIF2B). eIF2B is essential for protein synthesis and regulates translation in response to cellular stresses. We performed mutagenesis to introduce changes equivalent to 12 human CACH/VWM mutations in three subunits of the equivalent factor from yeast (Saccharomyces cerevisiae) and analyzed effects on cell growth, translation, and gene expression in response to stresses. None of the mutations is lethal or temperature sensitive, but almost all confer some defect in eIF2B function significant enough to alter growth or gene expression under normal or stress conditions. Biochemical analyses indicate that mutations analyzed in eIF2Balpha and -epsilon reduce the steady-state level of the affected subunit, while the most severe mutant tested, eIF2Bbeta(V341D) (human eIF2B(betaV316D)), forms complexes with reduced stability and lower eIF2B activity. eIF2Bdelta is excluded from eIF2Bbeta(V341D) complexes. eIF2B(betav341D) function can be rescued by overexpression of eIF2Bdelta alone. Our findings imply CACH/VWM mutations do not specifically impair responses to eIF2 phosphorylation, but instead cause protein structure defects that impair eIF2B activity. Altered protein folding is characteristic of other diseases, including cystic fibrosis and neurodegenerative disorders such as Huntington, Alzheimer's, and prion diseases.
Calakos N, Caffall Z J Clin Invest. 2024; 134(7).
PMID: 38557486 PMC: 10977992. DOI: 10.1172/JCI177833.
Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response.
Wek R, Anthony T, Staschke K Antioxid Redox Signal. 2023; 39(4-6):351-373.
PMID: 36943285 PMC: 10443206. DOI: 10.1089/ars.2022.0123.
Regulation and function of elF2B in neurological and metabolic disorders.
Hanson F, Hodgson R, Ribeiro de Oliveira M, Allen K, Campbell S Biosci Rep. 2022; 42(6).
PMID: 35579296 PMC: 9208314. DOI: 10.1042/BSR20211699.
GTP binding to translation factor eIF2B stimulates its guanine nucleotide exchange activity.
Kershaw C, Jennings M, Cortopassi F, Guaita M, Al-Ghafli H, Pavitt G iScience. 2021; 24(12):103454.
PMID: 34877508 PMC: 8633983. DOI: 10.1016/j.isci.2021.103454.
Khoury B, Shakir M, Hoang T BMJ Case Rep. 2021; 14(8).
PMID: 34433538 PMC: 8388307. DOI: 10.1136/bcr-2021-244788.